BMI, sex, and antidepressant response

Journal of Affective Disorders

Volumn 99, Issue 1-3, 2007, Pages 101-106

  Khan, Arif ^a,b   Schwartz, Kelly A ^a   Kolts, Russell L ^c   Brown, Walter A ^d,e  

^a Northwest Clinical Research Center   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c EASTERN WASHINGTON UNIVERSITY   (United States)

^d BROWN UNIVERSITY   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressant response; Body mass index; Clinical drug trials; Depression; Sex differences; SSRIs

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OBESITY; OUTPATIENT; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; SEX DIFFERENCE; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BODY MASS INDEX; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MATHEMATICAL COMPUTING; MIDDLE AGED; OBESITY; PERSONALITY INVENTORY; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS; SEX CHARACTERISTICS; SOFTWARE; TREATMENT OUTCOME;

EID: 33847034822     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.08.027     Document Type: Article

References (29)

1. Anderson G.D. Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J. Women's Health 14 (2005) 19-29
2. Baca E., Garcia-Garcia M., and Porras-Chavarino A. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 28 (2004) 57-65
3. Beierle I., Meibohm B., and Derendorg H. Gender differences in pharmacokinetics and pharmacodynamics. Int. J. Clin. Pharmacol. Ther. 37 (1999) 529-547
4. Bies R.R., Bigos K.L., and Pollock B.G. Gender differences in the pharmacokinetics and pharmacodynamics of antidepressants. J. Gend.-Specif. Med. 6 (2003) 12-20
5. Datz F.L., Christian P.E., and Moore J. Gender-related differences in gastric emptying. Nucl. Med. 28 (1987) 1204-1207
6. Dawkins K., and Potter W.Z. Gender differences in pharmacokinetics and pharmacodynamics of psychotropics: focus on women. Psychopharmacol. Bull. 27 (1991) 417-426
7. Food and Drug Administration. Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs. Fed. Regist. 58 (1993) 39406-39416
8. Frackiewicz E.J., Sramek J.J., and Cutler N.R. Gender differences in depression and antidepressant pharmacokinetics and adverse events. Ann. Pharmacother. 34 (2000) 80-88
9. Greenblatt D.J., Friedman H., Burstein E.S., Scavone J.M., Blyden G.T., Ochs H.R., Miller L.G., Harmatz J.S., and Shader R.I. Trazodone kinetics: effects of age, gender, and obesity. Clin. Pharmacol. Ther. 42 (1987) 193-200
10. Hamilton M. A rating scale of depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
11. Harris R.Z., Benet L.Z., and Schwartz J.B. Gender effects in pharmacokinetics and pharmacodynamics. Drugs 50 (1995) 222-239
12. Hildebrandt M.G., Steyerberg E.W., Stage K.B., Passchier J., and Kragh-Soerensen P. Are gender differences important for the clinical effects of antidepressants?. Am. J. Psychiatry 160 (2003) 1643-1650
13. Hudson W.R., Roehrkasse R.L., and Wald A. Influence of gender and menopause on gastric emptying and motility. Gastroenterology 96 (1989) 11-17
14. Kando J.C., Yonkers K.A., and Cole J.O. Gender as a risk factor for adverse events to medications. Drugs 50 (1995) 1-6
15. Khan A., Khan S.R., Shankles E.B., and Polissar N.L. Relative sensitivity of the Montgomery-Asberg Depression rating Scale, the Hamilton Depression rating Scale and the Clinical Global Impressions rating scale in antidepressant clinical trials. Int. Clin. Psychopharmacol. 17 6 (2002) 281-285
16. Khan A., Brodhead A.E., Schwartz K.A., Kolts R.L., and Brown W.A. Sex differences in antidepressant response in recent antidepressant clinical trials. J. Clin. Psychopharmacol. 25 (2005) 318-324
17. Kornstein S.G., Schatzberg A.F., Thase M.E., Yonkers K.A., McCullough J.P., Keitner G.I., Gelenberg A.J., Davis S.M., Harrison W.M., and Keller M.B. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am. J. Psychiatry 157 (2000) 1445-1452
18. Meibohm B., Beierle I., and Derendorf H. How important are gender differences in pharmacokinetics?. Clin. Pharmacokinet. 41 (2002) 329-342
19. Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979) 382-389
20. O'Malley K., Crooks J., Duke E., and Stevenson I.H. Effect of age and sex on human drug metabolism. Br. Med. J. 3 (1971) 607-609
21. Parker G., Parker K., Austin M.P., Mitchell P., and Brotchie H. Gender differences in response to differing antidepressant drug classes: two negative studies. Psychol. Med. 33 (2003) 1473-1477
22. Prange Jr. A.J., Wilson I.C., Rabon A.M., and Lipton M.A. Enhancement of imipramine antidepressant activity by thyroid hormone. Am. J. Psychiatry 126 (1969) 457-469
23. Quitkin F.M., Stewart J.W., McGrath P.J., Taylor B.P., Tisminetzky M.S., Petkova E., Chen Y., Guoguang M., and Klein D.F. Are there differences between women's and men's antidepressant responses?. Am. J. Psychiatry 159 (2002) 1848-1854
24. Sagud M., Hotujac L.J., Mihaljevic-Peles A., and Jakovljevic M. Gender differences in depression. Coll. Antropol. 26 (2002) 149-157
25. Schneider L., Small G., Hamilton S., Bystritsky A., Nemeroff C., and Meyers B. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Am. J. Geriatr. Psychiatry 5 (1997) 97-106
26. Thiels C., Linden M., Grieger F., and Leonard J. Gender differences in routine treatment of depressed outpatients with the selective serotonin reuptake inhibitor sertraline. Int. Clin. Psychopharmacol. 20 (2005) 1-7
27. Wohlfarth T., Storosum J.G., Elferink A.J.A., van Zwieten B.J., Fouwels A., and van den Brink W. Response to tricyclic antidepressants: independent of gender?. Am. J. Psychiatry 161 (2004) 370-372
28. Yonkers K.A., Kando J.C., Cole J.O., and Blumenthal S. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am. J. Psychiatry 149 (1992) 587-595
29. Zimmerman M., Mattia J.I., and Posternak M.A. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?. Am. J. Psychiatry 159 (2002) 469-473